Internal and Emergency Medicine

Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity

By Giuseppe Armentaro, Cristiana Vitale, Velia Cassano, Angela Sciacqua

Figure 1 from Internal and Emergency Medicine — Figure 1. Armentaro et al.

Non-randomised trial in 246 peopleInterventions

Declared ties to: University, Catanzaro, CATAnzaro Metabolic Risk and 3 more

The paper

Giuseppe Armentaro, Cristiana Vitale, Velia Cassano, Angela Sciacqua

Azienda Ospedaliero-Universitaria "Renato Dulbecco"; Magna Graecia University

Internal and Emergency Medicine, 20 Aug 2026

doi.org/10.1007/s11739-026-04499-4 PubMed 42622752

Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs
Nature Medicine4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity